Literature DB >> 7093116

Prazosin first dose phenomenon during combined treatment with a beta-adrenoceptor blocker in hypertensive patients.

P Seideman, A Grahnén, K Haglund, B Lindström, C Von Bahr.   

Abstract

1 The antihypertensive effect of prazosin has been studied in three groups of hypertensive patients. 2 The drug caused a significant reduction of blood pressure both as monotherapy and combined with alprenolol. 3 The effect of prazosin on blood pressure was more marked at the first dose and especially in combination with alprenolol. 4 No pharmacokinetic interaction between prazosin and alprenolol was observed. 5 Prazosin exhibits an exaggerated first dose effect together with alprenolol. Smaller starting doses of prazosin in combination therapy with beta-adrenoceptor blockers are warranted.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7093116      PMCID: PMC1402032          DOI: 10.1111/j.1365-2125.1982.tb01880.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  19 in total

1.  Double-blind studies of the clinical effectiveness of prazosin.

Authors:  H W Schnaper; A Oberman
Journal:  Postgrad Med       Date:  1975-11       Impact factor: 3.840

2.  Clinical experience with use of ultrasound sphygmomanometer.

Authors:  C F George; P J Lewis; A Petrie
Journal:  Br Heart J       Date:  1975-08

3.  Prazosin, a selective antagonist of post-synaptic alpha-adrenoceptors [proceedings].

Authors:  D Cambridge; M J Davey; R Massingham
Journal:  Br J Pharmacol       Date:  1977-03       Impact factor: 8.739

4.  [Apparatus for automatic indirect measurement of blood pressure].

Authors:  G Forssell; R Nordlander; O Nyquist; E Orinus
Journal:  Lakartidningen       Date:  1975-05-21

5.  Prazosin: severe side effects are dose-dependent.

Authors:  C Rosendorff
Journal:  Br Med J       Date:  1976-08-28

6.  Protein binding of drugs in uremic and normal serum: the role of endogenous binding inhibitors.

Authors:  I Sjöholm; A Kober; I Odar-Cederlöf; O Borgåa
Journal:  Biochem Pharmacol       Date:  1976-05-15       Impact factor: 5.858

Review 7.  Drug therapy. Binding of drugs to serum albumin (second of two parts).

Authors:  J Koch-Weser; E M Sellers
Journal:  N Engl J Med       Date:  1976-03-04       Impact factor: 91.245

8.  Prazosin: the first-dose phenomenon.

Authors:  R M Graham; I R Thornell; J M Gain; C Bagnoli; H F Oates; G S Stokes
Journal:  Br Med J       Date:  1976-11-27

9.  Prazosin in hypertension: a double-blind evaluation with methyldopa and placebo.

Authors:  W J Mroczek; S Fotiu; M E Davidov; F A Finnerty
Journal:  Curr Ther Res Clin Exp       Date:  1974-08

10.  Evaluation of beta blockade bendrofluazide, and prazosin in severe hypertension.

Authors:  A J Marshall; D W Barritt; J Pocock; S T Heaton
Journal:  Lancet       Date:  1977-02-05       Impact factor: 79.321

View more
  8 in total

Review 1.  Potentially significant drug interactions of class III antiarrhythmic drugs.

Authors:  Weeranuj Yamreudeewong; Michael DeBisschop; Linda G Martin; Dennis L Lower
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

2.  Profound hypotension after the first dose of ketanserin.

Authors:  P C Waller; H A Cameron; L E Ramsay
Journal:  Postgrad Med J       Date:  1987-04       Impact factor: 2.401

Review 3.  The management of hypertension.

Authors:  B N Prichard; C W Owens
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

4.  Hypertension. Current therapeutic practice reviewed.

Authors:  B N Prichard
Journal:  Drugs       Date:  1986       Impact factor: 9.546

Review 5.  Antipsychotic pharmacotherapy and orthostatic hypotension: identification and management.

Authors:  James J Gugger
Journal:  CNS Drugs       Date:  2011-08       Impact factor: 5.749

6.  Intraindividual comparison of moxonidine and prazosin in hypertensive patients.

Authors:  V Plänitz
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

7.  Comparative trial of felodipine and nifedipine in refractory hypertension.

Authors:  H Aberg; M Lindsjö; B Mörlin
Journal:  Drugs       Date:  1985       Impact factor: 9.546

Review 8.  Prazosin update. A review of its pharmacological properties and therapeutic use in hypertension and congestive heart failure.

Authors:  W F Stanaszek; D Kellerman; R N Brogden; J A Romankiewicz
Journal:  Drugs       Date:  1983-04       Impact factor: 9.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.